492: Investigating Novel Therapeutics to Improve Immune Function and Treat Age-Related Diseases - Dr. Joan Mannick - a podcast by Dr. Marie McNeely, featuring top scientists speaking about their life and c

Dr. Joan Mannick is Co-Founder and Chief Medical Officer of resTORbio, a clinical-stage biopharmaceutical company that develops novel therapeutics to treat aging-related diseases. Joan and her colleagues at resTORbio are targeting the biology of aging to treat and prevent aging-related diseases so people can be healthier longer. In particular, Joan is interested in targeting the aging immune system in an effort to reduce the risk of respiratory infections in older adults. After a busy day at work, Joan likes to relax by working out at the gym, watching movies, and reading novels. Joan received her B.A. from Harvard College and her M.D. from Harvard Medical School. She completed her residency in Internal Medicine at Brigham and Women’s Hospital and a fellowship in Infectious Disease at Harvard University. Joan then worked as a Medical Director at Genzyme and a faculty member at Harvard Medical School and the University of Massachusetts Medical School. Prior to joining resTORbio, Joan was Executive Director in the New Indications Discovery Unit of the Novartis Institutes of Biomedical research. In our interview Joan shares more about her life and science.

Further episodes of People Behind the Science Podcast - Stories from Scientists about Science, Life, Research, and Science Careers

Further podcasts by Dr. Marie McNeely, featuring top scientists speaking about their life and c

Website of Dr. Marie McNeely, featuring top scientists speaking about their life and c